Literature DB >> 7670249

Gonadal function and glycoprotein hormones in the carbohydrate-deficient glycoprotein (CDG) syndrome.

B Kristiansson1, H Stibler, L Wide.   

Abstract

Six females and six males with carbohydrate-deficient glycoprotein (CDG) syndrome type I, aged 4 months to 43 years, were examined for gonadal function and electrophoretic isoform patterns of four glycoprotein hormones: FSH, LH, TSH and erythropoietin. The female patients had a hypergonadotrophic hypogonadism from an early age without detectable ovaries in three cases. In the males, testosterone levels tended to be low with normal or slightly raised gonadotrophin values. None of the four glycoprotein hormone showed any signs of carbohydrate deficiency of the same type as in many liver-synthesized circulating glycoproteins. It is concluded that females with CDG syndrome type I have primary ovarian failure, and that the syndrome does not affect the terminal charged carbohydrate portion in gonadotrophins, TSH or erythropoietin. The characteristic carbohydrate deficiency in some circulating glycoproteins is thus not a generalized feature in this disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7670249     DOI: 10.1111/j.1651-2227.1995.tb13720.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  15 in total

Review 1.  New disorders in carbohydrate metabolism: congenital disorders of glycosylation and their impact on the endocrine system.

Authors:  Bradley S Miller; Hudson H Freeze
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

2.  The heart and pericardial effusions in CDGS-I (carbohydrate-deficient glycoprotein syndrome type I).

Authors:  B Kristiansson; H Stibler; N Conradi; B O Eriksson; W Ryd
Journal:  J Inherit Metab Dis       Date:  1998-04       Impact factor: 4.982

3.  Normal pubertal development in a female with carbohydrate deficient glycoprotein syndrome.

Authors:  M Pineda; C Pavia; M A Vilaseca; I Ferrer; T Temudo; A Chabas; H Stibler; J Jaeken
Journal:  Arch Dis Child       Date:  1996-03       Impact factor: 3.791

4.  Carbohydrate deficient glycoprotein (CDG) syndrome type I.

Authors:  J Jaeken; G Matthijs; R Barone; H Carchon
Journal:  J Med Genet       Date:  1997-01       Impact factor: 6.318

5.  Expanding the Spectrum of PMM2-CDG Phenotype.

Authors:  Sandrine Vuillaumier-Barrot; Bertrand Isidor; Thierry Dupré; Christiane Le Bizec; Albert David; Nathalie Seta
Journal:  JIMD Rep       Date:  2011-12-25

Review 6.  Congenital disorders of glycosylation.

Authors:  Irene J Chang; Miao He; Christina T Lam
Journal:  Ann Transl Med       Date:  2018-12

7.  High residual activity of PMM2 in patients' fibroblasts: possible pitfall in the diagnosis of CDG-Ia (phosphomannomutase deficiency).

Authors:  S Grünewald; E Schollen; E Van Schaftingen; J Jaeken; G Matthijs
Journal:  Am J Hum Genet       Date:  2001-01-11       Impact factor: 11.025

8.  UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase is indispensable for oogenesis, oocyte-to-embryo transition, and larval development of the nematode Caenorhabditis elegans.

Authors:  Nanako Kanaki; Ayako Matsuda; Katsufumi Dejima; Daisuke Murata; Kazuko H Nomura; Takashi Ohkura; Keiko Gengyo-Ando; Sawako Yoshina; Shohei Mitani; Kazuya Nomura
Journal:  Glycobiology       Date:  2019-02-01       Impact factor: 4.313

9.  Etiology of primary ovarian insufficiency in a series young girls presenting at a pediatric endocrinology center.

Authors:  Raja Brauner; Sophie Pierrepont; Joelle Bignon-Topalovic; Ken McElreavey; Anu Bashamboo
Journal:  Eur J Pediatr       Date:  2014-11-27       Impact factor: 3.183

10.  Congenital disorder of glycosylation type Ia: heterogeneity in the clinical presentation from multivisceral failure to hyperinsulinaemic hypoglycaemia as leading symptoms in three infants with phosphomannomutase deficiency.

Authors:  B Shanti; M Silink; K Bhattacharya; N J Howard; K Carpenter; M Fietz; P Clayton; J Christodoulou
Journal:  J Inherit Metab Dis       Date:  2009-04-27       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.